Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pleural Effusion 1Pituitary Diseases 1Pituitary ACTH Hypersecretion 1Myasthenia Gravis 1Lung Neoplasms 1Endometrial Neoplasms 1Adenocarcinoma of Lung 1ACTH-Secreting Pituitary Adenoma 1

Interventions

Pemetrexed 6pembrolizumab 5Magnetic Resonance Spectroscopy 5Carboplatin 5Specimen Handling 4Mastectomy, Segmental 4Cisplatin 4Bevacizumab 4durvalumab 2Platinum 2Biopsy 2tislelizumab 1osimertinib 1methyl-4-fluoro-4-deoxyglucose 1methoxyamine 1fludarabine phosphate 1devimistat 1dehydroftorafur 1defactinib 1dapagliflozin 1capmatinib 1aflutinib 1Standard of Care 1Smoking Devices 1Radiotherapy 1Radiation 1RO5126766 1Practice Guidelines as Topic 1Observation 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Adenocarcinoma of Lung × Biomarkers × Clear all
NCT07012759 2026-03-05

Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients

Fu Jen Catholic University

Recruiting
100 enrolled
Thoracic

Adenocarcinoma of Lung, Lung Neoplasms, Pleural Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡